Alyeska Investment Group
SWAV

Alyeska Investment Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Alyeska Investment Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,523
Closed -$8.1M – 654
2023
Q4 		$8.1M Sell
42,523
-83,063
-66% -$15.7M 0.05% 279
2023
Q3 		$25M Buy
+125,586
New +$29.7M 0.17% 175
2023
Q2 		– Sell
-124,605
Closed -$27M – 646
2023
Q1 		$27M Buy
124,605
+76,605
+160% +$14.9M 0.24% 130
2022
Q4 		$9.87M Buy
+48,000
New +$12.1M 0.1% 210
2020
Q3 		– Sell
-42,970
Closed -$2.04M – 612
2020
Q2 		$2.04M Buy
+42,970
New +$1.77M 0.03% 355
2020
Q1 		– Sell
-63,708
Closed -$2.8M – 496
2019
Q4 		$2.8M Sell
63,708
-44,560
-41% -$1.65M 0.04% 270
2019
Q3 		$3.24M Buy
108,268
+88,238
+441% +$3.75M 0.05% 259
2019
Q2 		$1.14M Sell
20,030
-50,182
-71% -$2.44M 0.01% 361
2019
Q1 		$2.35M Buy
+70,212
New +$2.33M 0.03% 272

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alyeska Investment Group's SWAV Position: Q1 2024 in Review

Alyeska Investment Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 42,523 shares — an estimated $8.1M sold.

Alyeska Investment Group first reported a position in SWAV in Q1 2019 and held it in 9 quarters. The position peaked at $27M in Q1 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Alyeska Investment Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 42,523 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $8.1M.
  • Alyeska Investment Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Alyeska Investment Group's Shockwave Medical, Inc. Common Stock position peaked at $27M in Q1 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.